Clinical Trial: Pharmacokinetics of Citalopram in Patients With Short Bowel Syndrome

Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional

Official Title: Study to Determine Steady-state Level of Citalopram Pharmacokinetic Parameters in Patients With Short Bowel Syndrome

Brief Summary: This prospective study will determine the pharmacokinetic parameters of citalopram in 12 adult patients with short bowel syndrome. While data on the prevalence of depression in patients with short bowel syndrome is sparse, the investigators' experience is that these patients have a high incidence of depression and should benefit from a psychopharmacological intervention.

Detailed Summary:
Sponsor: University of Nebraska

Current Primary Outcome: Measure plasma concentration of citalopram [ Time Frame: Seven days ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: University of Nebraska

Dates:
Date Received: April 2, 2009
Date Started: May 2010
Date Completion: April 2013
Last Updated: May 19, 2014
Last Verified: May 2014